BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36262801)

  • 21. Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation.
    Bakhtiar S; Kaffenberger C; Salzmann-Manrique E; Donhauser S; Lueck L; Karaca NE; Gonzalez-Granado LI; Hazar E; Keles S; Seidel MG; Fekadu J; Königs C; Schubert R; Bader P; Huenecke S
    J Autoimmun; 2022 Oct; 132():102891. PubMed ID: 36113303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Expression of LRBA and CTLA-4 Proteins in Common Variable Immunodeficiency Patients.
    Salami F; Fekrvand S; Yazdani R; Shahkarami S; Azizi G; Bagheri Y; Delavari S; Shariati S; Mahdaviani SA; Nabavi M; Shirkani A; Abolhassani H; Samadi M; Aghamohammadi A
    Immunol Invest; 2022 Feb; 51(2):381-394. PubMed ID: 33191838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTLA4 Message Reflects Pathway Disruption in Monogenic Disorders and Under Therapeutic Blockade.
    Garcia-Perez JE; Baxter RM; Kong DS; Tobin R; McCarter M; Routes JM; Verbsky J; Jordan MB; Dutmer CM; Hsieh EWY
    Front Immunol; 2019; 10():998. PubMed ID: 31156616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.
    Bratanič N; Kovač J; Pohar K; Trebušak Podkrajšek K; Ihan A; Battelino T; Avbelj Stefanija M
    Orphanet J Rare Dis; 2017 Jul; 12(1):131. PubMed ID: 28720148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review.
    Habibi S; Zaki-Dizaji M; Rafiemanesh H; Lo B; Jamee M; Gámez-Díaz L; Salami F; Kamali AN; Mohammadi H; Abolhassani H; Yazdani R; Aghamohammadi A; Anaya JM; Azizi G
    J Allergy Clin Immunol Pract; 2019; 7(7):2379-2386.e5. PubMed ID: 30995531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
    Schwab C; Gabrysch A; Olbrich P; Patiño V; Warnatz K; Wolff D; Hoshino A; Kobayashi M; Imai K; Takagi M; Dybedal I; Haddock JA; Sansom DM; Lucena JM; Seidl M; Schmitt-Graeff A; Reiser V; Emmerich F; Frede N; Bulashevska A; Salzer U; Schubert D; Hayakawa S; Okada S; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Sumnik Z; Sediva A; Slatter M; Arkwright PD; Cant A; Lorenz HM; Giese T; Lougaris V; Plebani A; Price C; Sullivan KE; Moutschen M; Litzman J; Freiberger T; van de Veerdonk FL; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Speckmann C; Ehl S; Leichtner A; Blumberg R; Franke A; Snapper S; Zeissig S; Cunningham-Rundles C; Giulino-Roth L; Elemento O; Dückers G; Niehues T; Fronkova E; Kanderová V; Platt CD; Chou J; Chatila TA; Geha R; McDermott E; Bunn S; Kurzai M; Schulz A; Alsina L; Casals F; Deyà-Martinez A; Hambleton S; Kanegane H; Taskén K; Neth O; Grimbacher B
    J Allergy Clin Immunol; 2018 Dec; 142(6):1932-1946. PubMed ID: 29729943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.
    Gámez-Díaz L; August D; Stepensky P; Revel-Vilk S; Seidel MG; Noriko M; Morio T; Worth AJJ; Blessing J; Van de Veerdonk F; Feuchtinger T; Kanariou M; Schmitt-Graeff A; Jung S; Seneviratne S; Burns S; Belohradsky BH; Rezaei N; Bakhtiar S; Speckmann C; Jordan M; Grimbacher B
    J Allergy Clin Immunol; 2016 Jan; 137(1):223-230. PubMed ID: 26768763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological phenotype of the murine Lrba knockout.
    Gámez-Díaz L; Neumann J; Jäger F; Proietti M; Felber F; Soulas-Sprauel P; Perruzza L; Grassi F; Kögl T; Aichele P; Kilimann M; Grimbacher B; Jung S
    Immunol Cell Biol; 2017 Oct; 95(9):789-802. PubMed ID: 28652580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Presentations of LRBA Deficiency: a Single-Center Experience.
    Kostel Bal S; Haskologlu S; Serwas NK; Islamoglu C; Aytekin C; Kendirli T; Kuloglu Z; Yavuz G; Dalgic B; Siklar Z; Kansu A; Ensari A; Boztug K; Dogu F; Ikinciogullari A
    J Clin Immunol; 2017 Nov; 37(8):790-800. PubMed ID: 28956255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipopolysaccharide Responsive Beige-like Anchor Protein Deficiency in a Patient with Autoimmune Lymphoproliferative Syndrome-like Disease Phenotype: A Case Report and Literature Review.
    Fetyan S; Sakrani NF; Yassin F; Abdallah MF; Elzein N; Azizi G; ElGhazali G
    Iran J Allergy Asthma Immunol; 2022 Apr; 21(2):219-227. PubMed ID: 35490276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score.
    Tesch VK; Abolhassani H; Shadur B; Zobel J; Mareika Y; Sharapova S; Karakoc-Aydiner E; Rivière JG; Garcia-Prat M; Moes N; Haerynck F; Gonzales-Granado LI; Santos Pérez JL; Mukhina A; Shcherbina A; Aghamohammadi A; Hammarström L; Dogu F; Haskologlu S; İkincioğulları AI; Köstel Bal S; Baris S; Kilic SS; Karaca NE; Kutukculer N; Girschick H; Kolios A; Keles S; Uygun V; Stepensky P; Worth A; van Montfrans JM; Peters AMJ; Meyts I; Adeli M; Marzollo A; Padem N; Khojah AM; Chavoshzadeh Z; Avbelj Stefanija M; Bakhtiar S; Florkin B; Meeths M; Gamez L; Grimbacher B; Seppänen MRJ; Lankester A; Gennery AR; Seidel MG;
    J Allergy Clin Immunol; 2020 May; 145(5):1452-1463. PubMed ID: 31887391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing SKIN health and safety in aged CARE (SKINCARE Trial): a study protocol for an exploratory cluster-randomized pragmatic trial.
    Kottner J; Hahnel E; El Genedy M; Neumann K; Balzer K
    Trials; 2019 May; 20(1):302. PubMed ID: 31142364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical Manifestation of LPS-Responsive Beige-Like Anchor Deficiency Syndrome as an Autoimmune Endocrine Disorder without Enteropathy and Immunodeficiency.
    Bakhtiar S; Ruemmele F; Charbit-Henrion F; Lévy E; Rieux-Laucat F; Cerf-Bensussan N; Bader P; Paetow U
    Front Pediatr; 2016; 4():98. PubMed ID: 27683652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying Novel Mutations in Iranian Patients with LPS-responsive Beige-like Anchor Protein (LRBA) Deficiency.
    Ghaini M; Arzanian MT; Shamsian BS; Sadr S; Rohani P; Keramatipour M; Mesdaghi M; Eskandarzadeh S; Lo B; Jamee M; Chavoshzadeh Z
    Immunol Invest; 2021 May; 50(4):399-405. PubMed ID: 32476511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency.
    Boz V; Valencic E; Girardelli M; Pin A; Gàmez-Diaz L; Tommasini A; Lega S; Bramuzzo M
    Front Immunol; 2021; 12():619246. PubMed ID: 33717114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Various phenotypes of
    Yao J; Gu H; Mou W; Chen Z; Ma J; Ma H; Li N; Zhang R; Wang T; Jiang J; Wu R
    Int J Immunopathol Pharmacol; 2022; 36():3946320221125591. PubMed ID: 36074705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study.
    Azizi G; Abolhassani H; Mahdaviani SA; Chavoshzadeh Z; Eshghi P; Yazdani R; Kiaee F; Shaghaghi M; Mohammadi J; Rezaei N; Hammarström L; Aghamohammadi A
    Pediatr Allergy Immunol; 2017 Aug; 28(5):478-484. PubMed ID: 28512785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
    Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
    Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy.
    Ureshino H; Koarada S; Kamachi K; Yoshimura M; Yokoo M; Kubota Y; Ando T; Ichinohe T; Morio T; Kimura S
    Int J Hematol; 2020 Jun; 111(6):897-902. PubMed ID: 31993940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.